Torben Harsløf

2.5k total citations
81 papers, 1.8k citations indexed

About

Torben Harsløf is a scholar working on Orthopedics and Sports Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Torben Harsløf has authored 81 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Orthopedics and Sports Medicine, 31 papers in Molecular Biology and 31 papers in Oncology. Recurrent topics in Torben Harsløf's work include Bone health and osteoporosis research (38 papers), Bone health and treatments (29 papers) and Bone Metabolism and Diseases (20 papers). Torben Harsløf is often cited by papers focused on Bone health and osteoporosis research (38 papers), Bone health and treatments (29 papers) and Bone Metabolism and Diseases (20 papers). Torben Harsløf collaborates with scholars based in Denmark, Netherlands and Germany. Torben Harsløf's co-authors include Bente Langdahl, Anne Sophie Sølling, Steen B. Pedersen, Katrine Hygum, Jakob Starup‐Linde, Peter Vestergaard, Lars Rejnmark, Marie Juul Ørnstrup, Thomas Kjær and Lars Rolighed and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Clinical Endocrinology & Metabolism and Journal of Bone and Mineral Research.

In The Last Decade

Torben Harsløf

77 papers receiving 1.8k citations

Peers

Torben Harsløf
Ling Oei Netherlands
Ann E. Kearns United States
Jordi Farrerons Spain
Aline G. Costa United States
Giuseppe Girasole Italy
Daniela Merlotti Italy
David W. Donley United States
Zhifeng Sheng China
Leslie S. Eldeiry United States
Michael Maricic United States
Ling Oei Netherlands
Torben Harsløf
Citations per year, relative to Torben Harsløf Torben Harsløf (= 1×) peers Ling Oei

Countries citing papers authored by Torben Harsløf

Since Specialization
Citations

This map shows the geographic impact of Torben Harsløf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Torben Harsløf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Torben Harsløf more than expected).

Fields of papers citing papers by Torben Harsløf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Torben Harsløf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Torben Harsløf. The network helps show where Torben Harsløf may publish in the future.

Co-authorship network of co-authors of Torben Harsløf

This figure shows the co-authorship network connecting the top 25 collaborators of Torben Harsløf. A scholar is included among the top collaborators of Torben Harsløf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Torben Harsløf. Torben Harsløf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vestergaard, Peter, et al.. (2025). Skin Autofluorescence May Contribute to Prediction of Low Bone Quality in Type 1 Diabetes—A Clinical Cross‐Sectional Study. Diabetes/Metabolism Research and Reviews. 41(6). e70080–e70080. 1 indexed citations
2.
Vestergaard, Peter, et al.. (2025). Association Between Muscle Status and Bone Size, Density, and Strength in Type 1 Diabetes: A Cross-sectional Study. The Journal of Clinical Endocrinology & Metabolism. 110(12). e4011–e4022.
3.
Starup‐Linde, Jakob, et al.. (2025). Prevalence and risk factors for osteoporosis in type 1 diabetes—results from an observational study. Osteoporosis International. 36(5). 823–831. 1 indexed citations
4.
Sølling, Anne Sophie, Torben Harsløf, Niklas Rye Jørgensen, & Bente Langdahl. (2022). Changes in RANKL and TRAcP 5b after discontinuation of denosumab suggest RANKL mediated formation of osteoclasts results in the increased bone resorption. Osteoporosis International. 34(3). 599–605. 13 indexed citations
5.
Sølling, Anne Sophie, Elena Tsourdi, Torben Harsløf, & Bente Langdahl. (2022). Denosumab Discontinuation. Current Osteoporosis Reports. 21(1). 95–103. 26 indexed citations
6.
Harsløf, Torben, et al.. (2021). Determinants of hypercalciuria and renal calcifications in chronic hypoparathyroidism: A cross‐sectional study. Clinical Endocrinology. 95(2). 286–294. 8 indexed citations
7.
Sølling, Anne Sophie, Torben Harsløf, Niels Henrik Bruun, & Bente Langdahl. (2021). The predictive value of bone turnover markers during discontinuation of alendronate: the PROSA study. Osteoporosis International. 32(8). 1557–1566. 6 indexed citations
8.
Starup‐Linde, Jakob, Katrine Hygum, Torben Harsløf, & Bente Langdahl. (2019). Type 1 Diabetes and Bone Fragility: Links and Risks. SHILAP Revista de lepidopterología.
9.
Starup‐Linde, Jakob, Katrine Hygum, Torben Harsløf, & Bente Langdahl. (2019). <p>Type 1 Diabetes and Bone Fragility: Links and Risks</p>. Diabetes Metabolic Syndrome and Obesity. Volume 12. 2539–2547. 37 indexed citations
10.
Rolighed, Lars, et al.. (2019). Primary hyperparathyroidism and recurrent ventricular tachyarrhythmia in a patient with novel RyR2 variant but without structural heart disease. SHILAP Revista de lepidopterología. 7(10). 1907–1912. 3 indexed citations
11.
Harsløf, Torben, Lars Rolighed, & Lars Rejnmark. (2019). Huge variations in definition and reported incidence of postsurgical hypoparathyroidism: a systematic review. Endocrine. 64(1). 176–183. 49 indexed citations
12.
Hald, Jannie Dahl, Lars Folkestad, Torben Harsløf, Kim Brixen, & Bente Langdahl. (2017). Health-Related Quality of Life in Adults with Osteogenesis Imperfecta. Calcified Tissue International. 101(5). 473–478. 25 indexed citations
13.
Sølling, Anne Sophie, et al.. (2016). Hypercalcemia after discontinuation of long-term denosumab treatment. Osteoporosis International. 27(7). 2383–2386. 34 indexed citations
14.
Ørnstrup, Marie Juul, et al.. (2016). Resveratrol Increases Osteoblast Differentiation In Vitro Independently of Inflammation. Calcified Tissue International. 99(2). 155–163. 45 indexed citations
15.
Hald, Jannie Dahl, Lars Folkestad, Torben Harsløf, et al.. (2016). Skeletal phenotypes in adult patients with osteogenesis imperfecta—correlations with COL1A1/COL1A2 genotype and collagen structure. Osteoporosis International. 27(11). 3331–3341. 37 indexed citations
16.
Harsløf, Torben, et al.. (2016). Mesh shrinkage depends on mesh properties and anchoring device: an experimental long-term study in sheep. Hernia. 21(1). 107–113. 17 indexed citations
17.
Dige, Anders, Bent Deleuran, Jens Frederik Dahlerup, et al.. (2015). Flow cytometry detection of vitamin D receptor changes during vitamin D treatment in Crohn's disease. Clinical & Experimental Immunology. 181(1). 19–28. 17 indexed citations
18.
Langdahl, Bente & Torben Harsløf. (2011). Medical Treatment of Osteoporotic Vertebral Fractures. Therapeutic Advances in Musculoskeletal Disease. 3(1). 17–29. 23 indexed citations
19.
Harsløf, Torben, Lise B. Husted, M. Carstens, et al.. (2011). The Expression and Regulation of Bone-acting Cytokines in Human Peripheral Adipose Tissue in Organ Culture. Hormone and Metabolic Research. 43(7). 477–482. 11 indexed citations
20.
Knudsen, Søren Tang, et al.. (2007). The Effect of Interleukin-1α Polymorphisms on Bone Mineral Density and the Risk of Vertebral Fractures. Calcified Tissue International. 80(1). 21–30. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ling Oei Breakdown of academic impact, for papers by Ann E. Kearns Breakdown of academic impact, for papers by Jordi Farrerons Breakdown of academic impact, for papers by Aline G. Costa Breakdown of academic impact, for papers by Giuseppe Girasole Breakdown of academic impact, for papers by Daniela Merlotti Breakdown of academic impact, for papers by David W. Donley Breakdown of academic impact, for papers by Zhifeng Sheng Breakdown of academic impact, for papers by Leslie S. Eldeiry Breakdown of academic impact, for papers by Michael Maricic
Rankless by CCL
2026